J & K DEAN LIMITED

Company number 13249191 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

J & K DEAN LIMITED - Analysis Report

Company Number: 13249191

Analysis Date: 2025-07-20 12:42 UTC

Financial Health Assessment for J & K Dean Limited


1. Financial Health Score: B

Explanation:
J & K Dean Limited demonstrates solid financial footing with strong asset backing and improving net asset value. However, the company carries significant long-term liabilities and very tight working capital, which are symptoms warranting cautious monitoring. The positive fair value revaluation of investment property signals good asset quality, but liquidity and debt structure present mild concerns.


2. Key Vital Signs

Metric Latest Value (2024) Interpretation
Fixed Assets (Investment Property + Tangible Assets) £700,373 High-value long-term assets indicate stable capital base.
Current Assets £13,696 Minimal short-term resources available; potentially tight liquidity.
Cash at Bank £7,156 Low cash reserves, signalling potential cash flow constraints.
Current Liabilities £13,202 Short-term obligations roughly match current assets, indicating neutral working capital.
Net Current Assets (Working Capital) £494 Almost breakeven working capital; very thin margin to cover short-term debts.
Long-term Liabilities £357,147 Significant debts due beyond one year; leverage risk present.
Net Assets (Equity) £257,914 Positive and growing equity base, reflecting retained earnings and asset revaluation.
Fair Value Reserve (Investment Property gains) £257,140 Reflects unrealised gains on property assets, improving balance sheet strength.

3. Diagnosis: Business Health Overview

J & K Dean Limited’s financial "vital signs" portray a company with a solid "skeleton" of investment property assets that have appreciated significantly (£600k to £700k in one year). This revaluation acts like a healthy "muscle tone" in the balance sheet, reinforcing net asset value to £257k in 2024 from £185k in 2023.

However, the "circulatory system" — the company's liquidity and working capital — shows signs of strain. Current assets barely cover current liabilities, and cash reserves have halved year-on-year (£14,238 in 2023 to £7,156 in 2024). This thin buffer (working capital of £494) is a symptom of tight operational cash flow management or timing differences in receivables and payables.

The company carries substantial long-term liabilities (£357k), akin to a heavy "debt load," which it must service over time. While these are not immediately due, they pose a risk if cash flows weaken or asset values decline. The provision for liabilities (£85k) also indicates some contingent or future obligations that could pressure finances.

Overall, the company has a robust asset base and equity position but shows cautious signs of liquidity stress and high leverage. The business appears stable but requires careful management of cash flows and debt.


4. Recommendations: Prescriptions for Financial Wellness

  • Strengthen Cash Flow Management:
    Close monitoring and improvement of cash conversion cycles are essential. Accelerate debtor collections and negotiate extended payment terms with creditors to build a healthier cash buffer.

  • Review Debt Structure:
    Explore refinancing options to potentially extend or reduce high long-term liabilities. Lowering interest costs or easing repayment terms can reduce financial strain.

  • Maintain Asset Valuations Vigilantly:
    As investment property forms the backbone of net assets, regularly verify fair value assessments and monitor market conditions to avoid sudden impairment.

  • Build Working Capital Reserves:
    Aim to improve net current assets to a comfortable positive level (e.g., ≥£10k), providing a safety net against short-term liquidity shocks.

  • Plan for Contingent Liabilities:
    Investigate the nature of provisions and create reserves or strategies to mitigate their impact when they crystallize.

  • Enhance Financial Reporting:
    While exempt from audit, consider voluntary audits or reviews to increase stakeholder confidence and identify early financial risks.


Summary Using Medical Analogy

J & K Dean Limited's financial health shows a strong "bone structure" with valuable investment property assets and growing equity. However, the "circulatory system" (cash flow and working capital) is weak, risking short-term distress. The significant "debt burden" requires careful management to avoid chronic financial illness. With timely interventions to boost liquidity and manage liabilities, the company’s prognosis is positive.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.